Aventiv Research | Aventiv Research Columbus

Research site
99 North Brice Road Suite 260, Columbus, Ohio, United States of America
Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site


3 of 7
Status: Active
Trial type: Interventional
Funder type: Industry

A Phase 3 Study to Evaluate Safety and Biomarkers of Resmetirom (MGL-3196) in Patients With Non-alcoholic Fatty Liver Disease (NAFLD), MAESTRO-NAFLD-Open-Label-Extension (MAESTRO-NAFLD-OLE)

A 52-Week, Multi-center, Open-label, Active Treatment Extension Study to Evaluate Safety and Tolerability of Once Daily, Oral Administration of Resme...

Non-Alcoholic Fatty Liver Disease
Drug: Resmetirom

Migraine is a common neurological disorder typically characterized by attacks of throbbing, moderate to severe headache, often associated with nausea...

Drug: Ubrogepant

The purpose of this study is to assess the safety and immunogenicity of a single intramuscular (IM) injection of 3 dose-levels of a respiratory syncy...

Respiratory Syncytial Virus Immunization
Biological: RSV mRNA LNP CL-0137 High RSV mRNA LNP CL-0137 High Dose Dose
Biological: RSV mRNA LNP CL-0137 Medium Dose

Trial conditions

Migraine Disorders (3 trials)
Fatty Liver (2 trials)
Liver Diseases (2 trials)
Non-alcoholic Fatty Live... (2 trials)
Cardiovascular Diseases (1 trial)
Hypogonadism (1 trial)
Respiratory Syncytial Vi... (1 trial)

Clinical trials

Find clinical trialsTrials by location


© Copyright 2024 Veeva Systems